20 Questions To See If You Can Retire Comfortably
Finding the right financial advisor to fit your needs doesn't have to be hard. SmartAsset's free quiz matches you with fiduciary financial advisors in your area in 5 minutes. Each advisor is legally bound to act in your best interest.
If you're ready to acheive your financial goals, get started now.
pixel

REGN Insider Trading (Regeneron Pharmaceuticals)

Insider Ownership Percentage: 11.84%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $241,655,911.53

Regeneron Pharmaceuticals Insider Trading History Chart

Regeneron Pharmaceuticals Share Price & Price History

$458.60
▼ -9.43 (-2.01%)
As of 02/24/2021 01:00 AM ET
Days: 30 | 90 | 365
This stock could soar as cannabis beverage sales hit $2.5 billion
A popular Seattle cannabis manufacturer is now partnering with other companies to produce a new line of cannabis-infused beverages. It’s perfect timing. A new report reveals cannabis beverage sales will reach $2.8 billion by 2025, expanding at an annual compounded rate of 17.8%. A huge opportunity!
Find out why this could be the #1 penny stock

Regeneron Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/25/2021Michael S BrownDirectorSell2,480$554.32$1,374,713.603,371  
12/1/2020Arthur F RyanDirectorSell100$520.48$52,048.0023,741  
11/2/2020Arthur F RyanDirectorSell100$548.54$54,854.0027,323  
10/5/2020Joseph L GoldsteinDirectorSell9,212$600.00$5,527,200.0014,855  
10/5/2020Marion MccourtSVPSell1,000$600.00$600,000.0014,963  
9/22/2020Joseph L GoldsteinDirectorSell16,574$549.87$9,113,545.38
8/31/2020George L SingDirectorSell10,000$612.06$6,120,600.0060,815  
8/31/2020Joseph J LarosaEVPSell4,672$615.04$2,873,466.8820,438  
8/25/2020Plew Daniel P VanEVPSell27,109$610.89$16,560,617.0136,854  
8/24/2020George L SingDirectorSell61,000$605.40$36,929,400.00111,632  
8/21/2020Joseph L GoldsteinDirectorSell1,000$617.18$617,180.00111,632  
8/11/2020P Roy VagelosDirectorSell33,460$602.94$20,174,372.40234,649  
8/4/2020Robert E LandryCFOSell696$654.46$455,504.1623,973  
8/3/2020Arthur F RyanDirectorSell100$641.93$64,193.0028,640  
7/21/2020Christopher R FenimoreVPSell3,709$642.04$2,381,326.3625,277  
7/21/2020Robert E LandryCFOSell391$647.58$253,203.7827,473  
7/14/2020Andrew J MurphyEVPSell2,380$633.48$1,507,682.4044,067  
7/14/2020Robert E LandryCFOSell579$640.50$370,849.5023,973  
7/8/2020Robert E LandryCFOSell1,160$639.66$742,005.6033,973  
7/7/2020George L SingDirectorSell7,500$650.00$4,875,000.00122,915  
7/1/2020Michael S BrownDirectorSell3,613$607.62$2,195,331.064,256  
6/29/2020George L SingDirectorSell3,000$608.91$1,826,730.00115,415  
6/29/2020Robert E LandryCFOSell400$612.57$245,028.0024,334  
6/19/2020Bonnie L BasslerDirectorSell2,559$630.02$1,612,221.183,202  
6/16/2020Christopher R FenimoreVPSell3,556$590.89$2,101,204.8420,323  
6/11/2020Huda Y ZoghbiDirectorSell3,412$588.39$2,007,586.68
6/9/2020Robert E LandryCFOSell4,271$606.59$2,590,745.89
6/8/2020Joseph L GoldsteinDirectorSell10,838$608.59$6,595,898.42
6/5/2020Bonnie L BasslerDirectorSell2,559$600.00$1,535,400.003,202  
6/1/2020Arthur F RyanDirectorSell100$603.23$60,323.0028,838  
5/28/2020George L SingDirectorSell1,000$579.00$579,000.00115,415  
5/21/2020P Roy VagelosChairmanSell783$577.49$452,174.67307,849  
5/13/2020George L SingDirectorSell5,000$580.00$2,900,000.00120,415  
5/12/2020Leonard S SchleiferCEOSell150,922$569.22$85,907,820.84599,499  
5/11/2020George L SingDirectorSell850$575.00$488,750.00120,415  
5/6/2020Joseph L GoldsteinDirectorSell2,000$560.00$1,120,000.007,643  
5/1/2020Arthur F RyanDirectorSell100$520.37$52,037.0028,931  
4/20/2020Joseph J LarosaEVPSell1,778$570.30$1,013,993.4015,547  
4/20/2020Robert E LandryCFOSell3,250$566.94$1,842,555.0028,373  
4/17/2020Joseph J LarosaEVPSell2,267$557.38$1,263,580.4619,438  
4/17/2020Robert E LandryCFOSell991$557.68$552,660.8828,373  
4/15/2020Robert E LandryCFOSell853$518.49$442,271.9727,873  
4/14/2020Neil StahlEVPSell5,497$521.07$2,864,321.7924,459  
4/13/2020Robert E LandryCFOSell828$509.79$422,106.1227,873  
4/7/2020Robert E LandryCFOSell696$497.52$346,273.9227,373  
4/2/2020Joseph J LarosaEVPSell6,797$489.98$3,330,394.0619,438  
4/2/2020Robert E LandryCFOSell105$495.88$52,067.4025,092  
4/1/2020Arthur F RyanDirectorSell100$483.85$48,385.0029,141  
4/1/2020Christopher R FenimoreVPSell1,200$488.41$586,092.0014,297  
3/30/2020Arthur F RyanDirectorSell100$466.69$46,669.0029,141  
2/27/2020Neil StahlEVPSell10,349$452.26$4,680,438.7436,380  
2/26/2020George L SingDirectorSell2,500$460.00$1,150,000.00117,915  
2/25/2020Robert E LandryCFOSell214$449.01$96,088.1425,973  
1/27/2020Andrew J MurphyEVPSell8,000$340.91$2,727,280.0057,751  
1/2/2020George L SingDirectorSell15,000$371.98$5,579,700.00130,095  
12/13/2019Christopher R FenimoreVPSell1,682$376.14$632,667.489,697  
12/13/2019P Roy VagelosChairmanSell51,842$376.04$19,494,665.68412,140  
11/27/2019Joseph L GoldsteinDirectorSell1,000$370.00$370,000.0011,323  
11/26/2019Neil StahlEVPSell4,006$364.07$1,458,464.4232,455  
11/25/2019P Roy VagelosChairmanSell22,149$363.83$8,058,470.67
11/22/2019Joseph L GoldsteinDirectorSell1,000$360.00$360,000.0011,323  
11/12/2019Michael S BrownDirectorSell4,500$349.00$1,570,500.004,823  
11/8/2019Joseph L GoldsteinDirectorSell1,000$340.44$340,440.0010,323  
11/8/2019Neil StahlEVPSell7,364$338.52$2,492,861.2821,150  
9/10/2019SanofiMajor ShareholderSell172,904$281.15$48,611,959.60
5/15/2019Joseph L GoldsteinDirectorSell1,000$305.93$305,930.0011,323  
5/14/2019Neil StahlEVPSell9,853$305.74$3,012,456.2247,450  
3/8/2019SanofiMajor ShareholderSell131,115$412.17$54,041,669.55  
1/10/2019Joseph L GoldsteinDirectorSell1,791$410.00$734,310.0014,114  
12/20/2018Christopher R FenimoreVPSell1,848$358.97$663,376.569,871  
12/12/2018P Roy VagelosChairmanSell6$382.32$2,293.92387,449  
9/27/2018Michael S BrownDirectorSell2,000$392.26$784,520.002,000  
9/24/2018Joseph L GoldsteinDirectorSell2,000$388.65$777,300.0013,000  
9/6/2018SanofiMajor ShareholderSell104,552$406.68$42,519,207.36  
8/22/2018Michael S BrownDirectorSell1,500$380.49$570,735.001,500  
8/2/2018Joseph L GoldsteinDirectorSell2,000$380.00$760,000.0014,000  
7/10/2018P Roy VagelosChairmanSell74,670$367.22$27,420,317.40553,121  
7/5/2018Joseph L GoldsteinDirectorSell2,000$360.00$720,000.0014,000  
6/21/2018P Roy VagelosChairmanSell74,710$327.87$24,495,167.70553,121  
6/8/2018SanofiMajor ShareholderSell121,601$309.31$37,612,405.31  
5/24/2018Neil StahlEVPSell11,407$295.09$3,366,091.6358,709  
5/9/2018George L SingDirectorSell7,000$285.29$1,997,030.00127,772  
3/19/2018Joseph L GoldsteinDirectorSell2,000$350.02$700,040.0014,000  
3/14/2018Joseph L GoldsteinDirectorSell2,000$340.00$680,000.0014,000  
See Full Table

SEC Filings (Institutional Ownership Changes) for Regeneron Pharmaceuticals (NASDAQ:REGN)

85.00% of Regeneron Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Regeneron Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
2/24/2021Alyeska Investment Group L.P.742$0.36M0.0%-92.6%0.001%
2/24/2021Bank Julius Baer & Co. Ltd Zurich861$0.42M0.0%+20.8%0.001%
2/23/2021Principal Financial Group Inc.141,880$68.54M0.1%-4.2%0.132%
2/22/2021Achmea Investment Management B.V.21,198$10.24M0.4%+36.3%0.020%
2/19/2021AtonRa Partners1,668$0.81M0.4%N/A0.002%
2/19/2021Rehmann Capital Advisory Group915$0.44M0.0%N/A0.001%
2/19/2021National Pension Service145,103$70.10M0.2%+9.9%0.135%
2/19/2021Laffer Tengler Investments380$0.18M0.1%N/A0.000%
2/18/2021First National Bank of Omaha8,495$4.10M0.2%+1.9%0.008%
2/18/2021Symmetry Partners LLC1,132$0.55M0.0%-44.6%0.001%
2/18/2021Intellectus Partners LLC3,280$1.59M0.5%+45.6%0.003%
2/18/2021Truist Financial Corp74,364$35.93M0.1%+11.7%0.069%
2/17/2021Voloridge Investment Management LLC43,195$20.87M0.2%-70.5%0.040%
2/17/2021IHT Wealth Management LLC633$0.31M0.0%+6.4%0.001%
2/17/2021United Capital Financial Advisers LLC2,372$1.15M0.0%+13.4%0.002%
2/17/2021Cim Investment Mangement Inc.1,145$0.55M0.2%N/A0.001%
2/17/2021MidWestOne Financial Group Inc.563$0.27M0.1%-29.8%0.001%
2/17/2021Canada Pension Plan Investment Board6,692$3.23M0.0%+24.1%0.006%
2/17/2021Krensavage Asset Management LLC82,200$39.71M11.6%-0.1%0.077%
2/17/2021Advisor Partners LLC1,706$0.82M0.1%-21.6%0.002%
2/17/2021Prestige Wealth Management Group LLC93$45K0.0%-48.6%0.000%
2/17/2021Cetera Investment Advisers2,276$1.10M0.0%N/A0.002%
2/17/2021Cetera Advisors LLC1,415$0.68M0.0%+164.5%0.001%
2/17/2021Cetera Advisor Networks LLC1,794$0.87M0.0%+12.1%0.002%
2/16/2021Oxler Private Wealth LLC1,710$0.65M0.4%N/A0.002%
2/16/2021Tokio Marine Asset Management Co. Ltd.2,457$1.19M0.1%+18.4%0.002%
2/16/2021Tri Locum Partners LP10,423$5.04M1.8%N/A0.010%
2/16/2021Glenmede Trust Co. NA106,982$51.68M0.3%-2.0%0.100%
2/16/2021Alyeska Investment Group L.P.742$0.36M0.0%-92.6%0.001%
2/16/2021Armistice Capital LLC132,000$63.77M2.9%+57.1%0.123%
2/16/2021Morgan Stanley547,337$264.43M0.0%+56.1%0.511%
2/16/2021Toroso Investments LLC770$0.37M0.0%+22.2%0.001%
2/16/2021LMR Partners LLP1,625$0.79M0.0%N/A0.002%
2/16/2021Knights of Columbus Asset Advisors LLC10,595$5.12M0.5%N/A0.010%
2/16/2021Nuveen Asset Management LLC814,786$393.63M0.1%-49.9%0.761%
2/16/2021Captrust Financial Advisors1,859$0.90M0.0%-12.3%0.002%
2/16/2021Colony Group LLC4,199$2.03M0.0%+15.3%0.004%
2/16/2021Guggenheim Capital LLC65,150$31.48M0.2%-0.1%0.061%
2/16/2021Price T Rowe Associates Inc. MD867,999$419.34M0.0%-5.0%0.810%
2/16/2021Sivik Global Healthcare LLC20,000$9.66M3.9%+100.0%0.019%
2/16/2021Vancity Investment Management Ltd13,520$6.53M1.3%N/A0.013%
2/16/2021Clough Capital Partners L P8,384$4.05M0.3%-64.0%0.008%
2/16/2021Wunderlich Capital Managemnt4,482$2.17M1.2%+0.5%0.004%
2/16/2021Kingsview Wealth Management LLC628$0.30M0.0%-36.9%0.001%
2/16/2021Amundi Pioneer Asset Management Inc.201,001$97.10M0.1%-8.9%0.188%
2/16/2021Virginia Retirement Systems ET AL120,300$58.12M0.6%+3.9%0.112%
2/16/2021ETF Managers Group LLC752$0.36M0.0%+19.2%0.001%
2/16/2021Schroder Investment Management Group26,203$12.66M0.0%-10.1%0.024%
2/16/2021Engineers Gate Manager LP2,113$1.02M0.0%-59.9%0.002%
2/16/2021Leuthold Group LLC11,926$5.76M0.8%-6.1%0.011%
2/16/2021Ashford Capital Management Inc.2,484$1.20M0.1%-16.9%0.002%
2/16/2021Gyon Technologies Capital Management LP629$0.30M0.1%N/A0.001%
2/16/2021Janus Henderson Group PLC381,823$184.46M0.1%+11.8%0.356%
2/16/2021A.R.T. Advisors LLC1,498$0.72M3.4%N/A0.001%
2/16/2021ExodusPoint Capital Management LP7,730$3.73M0.0%+167.5%0.007%
2/16/2021Sittner & Nelson LLC75$36K0.0%N/A0.000%
2/16/2021Benjamin F. Edwards & Company Inc.323$0.16M0.0%+53.1%0.000%
2/16/2021First Foundation Advisors1,157$0.56M0.0%N/A0.001%
2/16/2021Capital International Ltd.28,424$13.73M0.8%+1.1%0.027%
2/16/2021Parametrica Management Ltd1,773$0.86M0.5%N/A0.002%
2/16/2021Charles Schwab Investment Management Inc.516,149$249.36M0.1%+1.2%0.482%
2/13/2021Essex Investment Management Co. LLC7,276$3.52M0.4%-3.0%0.007%
2/13/2021Ontario Teachers Pension Plan Board1,523$0.74M0.0%-32.9%0.001%
2/13/2021American International Group Inc.46,407$22.42M0.1%+7.3%0.043%
2/13/2021Infrastructure Capital Advisors LLC500$0.24M0.1%-88.7%0.000%
2/13/2021Oak Associates Ltd. OH3,195$1.54M0.1%+6.5%0.003%
2/12/2021Stifel Financial Corp29,617$14.31M0.0%-26.0%0.028%
2/12/2021DCF Advisers LLC12,400$5.99M2.5%-5.3%0.012%
2/12/2021Laurion Capital Management LP427$0.21M0.0%N/A0.000%
2/12/2021Allstate Corp1,185$0.57M0.0%-39.1%0.001%
2/12/2021Brown Advisory Inc.2,281$1.10M0.0%-16.5%0.002%
2/12/2021Greenwich Wealth Management LLC16,129$7.79M0.6%+0.4%0.015%
2/12/2021Checchi Capital Advisers LLC662$0.32M0.0%-6.9%0.001%
2/12/2021Sequoia Financial Advisors LLC420$0.20M0.0%-8.1%0.000%
2/12/2021Caisse DE Depot ET Placement DU Quebec7,540$3.64M0.0%-29.9%0.007%
2/12/2021Vantage Consulting Group Inc153$74K0.0%N/A0.000%
2/12/2021CWM Advisors LLC4,961$2.40M0.5%+24.1%0.005%
2/12/2021Federated Hermes Inc.4,448$2.15M0.0%+14.8%0.004%
2/12/2021Corient Capital Partners LLC1,342$0.65M0.1%-23.4%0.001%
2/12/2021Raymond James Financial Services Advisors Inc.9,558$4.62M0.0%+1.7%0.009%
2/12/2021LPL Financial LLC35,208$17.01M0.0%+14.9%0.033%
2/12/2021Highlander Capital Management LLC150$72K0.0%+200.0%0.000%
2/12/2021Amalgamated Bank6,332$3.06M0.1%-0.4%0.006%
2/12/2021Public Employees Retirement System of Ohio60,976$29.46M0.1%+6.9%0.057%
2/12/2021The Manufacturers Life Insurance Company 96,508$46.62M0.0%-2.0%0.090%
2/12/2021Meiji Yasuda Life Insurance Co1,275$0.62M0.0%-30.1%0.001%
2/12/2021Montag A & Associates Inc.130$63K0.0%N/A0.000%
2/12/2021Paradigm Asset Management Co. LLC1,100$0.53M0.1%+10.0%0.001%
2/12/2021Cibc World Markets Corp28,695$13.86M0.1%+6.8%0.027%
2/12/2021Jaffetilchin Investment Partners LLC856$0.41M0.1%N/A0.001%
2/12/2021Ossiam72$35K0.0%-98.2%0.000%
2/12/2021Nomura Asset Management Co. Ltd.58,615$28.32M0.2%+14.2%0.055%
2/12/2021Eaton Vance Management28,822$13.92M0.0%-3.5%0.027%
2/12/2021Magnetar Financial LLC3,080$1.49M0.0%-2.5%0.003%
2/12/2021Nordea Investment Management AB48,114$23.24M0.0%+10.5%0.045%
2/12/2021Distillate Capital Partners LLC3,144$1.50M0.7%N/A0.003%
2/12/2021Regent Peak Wealth Advisors LLC160$77K0.0%N/A0.000%
2/12/2021Vontobel Holding Ltd.13,223$6.54M0.0%N/A0.012%
2/12/2021Asahi Life Asset Management CO. LTD.1,055$0.51M0.1%N/A0.001%
2/12/2021SRB Corp1,494$0.72M0.1%+59.6%0.001%
Data available starting January 2016

See Full Table
Regeneron Pharmaceuticals logo
Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for treating various medical conditions worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema (DME); myopic choroidal neovascularization; and diabetic retinopathy in patients with DME, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion. It also provides Dupixent injection to treat atopic dermatitis in adults, and asthma in adults and adolescents; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; and Kevzara solution for subcutaneous injection for treating rheumatoid arthritis in adults. In addition, the company offers Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer. Further, it is developing various product candidates for treating patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neuromuscular diseases, infectious diseases, and other diseases. The company has collaboration and license agreements with Sanofi; Bayer; Teva; Mitsubishi Tanabe Pharma; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Vyriad, Inc., as well as has an agreement with the U.S. Department of Health and Human Services. It has collaborations with Zai Lab Limited; Intellia Therapeutics, Inc.; and BioNTech. Regeneron Pharmaceuticals, Inc. was founded in 1988 and is headquartered in Tarrytown, New York.
Read More

Today's Range

Now: $458.60
$457.17
$469.47

50 Day Range

MA: $501.90
$460.58
$548.20

52 Week Range

Now: $458.60
$418.01
$664.64

Volume

1,097,477 shs

Average Volume

1,109,829 shs

Market Capitalization

$49.13 billion

P/E Ratio

16.76

Dividend Yield

N/A

Beta

0.3

Who are the company insiders with the largest holdings of Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals' top insider investors include:
  1. Leonard S Schleifer (CEO)
  2. P Roy Vagelos (Chairman)
  3. P Roy Vagelos (Director)
  4. George L Sing (Director)
  5. Joseph L Goldstein (Director)
  6. Andrew J Murphy (EVP)
  7. Neil Stahl (EVP)
  8. Plew Daniel P Van (EVP)
  9. Robert E Landry (CFO)
  10. Arthur F Ryan (Director)
  11. Christopher R Fenimore (VP)
  12. Joseph J Larosa (EVP)
  13. Marion Mccourt (SVP)
  14. Michael S Brown (Director)
  15. Bonnie L Bassler (Director)
  16. Huda Y Zoghbi (Director)
  17. Sanofi (Major Shareholder)

Who are the major institutional investors of Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals' top institutional investors include:
  1. FMR LLC — 10.76%
  2. BlackRock Inc. — 9.16%
  3. Alliancebernstein L.P. — 1.65%
  4. Northern Trust Corp — 1.16%
  5. Renaissance Technologies LLC — 0.85%
  6. Price T Rowe Associates Inc. MD — 0.81%

Which institutional investors are selling Regeneron Pharmaceuticals stock?

In the previous quarter, REGN stock was sold by these institutional investors:
  1. FMR LLC
  2. Nuveen Asset Management LLC
  3. First Trust Advisors LP
  4. Renaissance Technologies LLC
  5. Bessemer Group Inc.
  6. Voloridge Investment Management LLC
  7. Price T Rowe Associates Inc. MD
  8. Northern Trust Corp
During the previous year, company insiders that have sold Regeneron Pharmaceuticals company stock include:
  1. Leonard S Schleifer (CEO)
  2. P Roy Vagelos (Chairman)
  3. P Roy Vagelos (Director)
  4. George L Sing (Director)
  5. Joseph L Goldstein (Director)
  6. Andrew J Murphy (EVP)
  7. Neil Stahl (EVP)
  8. Plew Daniel P Van (EVP)
  9. Robert E Landry (CFO)
  10. Arthur F Ryan (Director)
  11. Christopher R Fenimore (VP)
  12. Joseph J Larosa (EVP)
  13. Marion Mccourt (SVP)
  14. Michael S Brown (Director)
  15. Bonnie L Bassler (Director)
  16. Huda Y Zoghbi (Director)

Which institutional investors are buying Regeneron Pharmaceuticals stock?

During the last quarter, REGN stock was purchased by institutional investors including:
  1. Alliancebernstein L.P.
  2. Morgan Stanley
  3. Assenagon Asset Management S.A.
  4. Brandywine Global Investment Management LLC
  5. Candriam Luxembourg S.C.A.
  6. NN Investment Partners Holdings N.V.
  7. Armistice Capital LLC
  8. Janus Henderson Group PLC
BREAKING NEWS
Two Legendary Energy Explorers Could Have Found One of the World’s Greatest Lithium Discoveries.
You’ll be astonished by what 7M Tons is worth